Diabeloop SAS announced that it has received 70 million in a round of funding led by new investor, LBO France on June 2, 2022. The transaction included participation from new investors, Terumo Corporation, Avenir Numerique, FCPI, Avenir Numérique 2, FCPI, funds managed by Innovacom Gestion, returning investors Centre d'Études et de Recherches sur l'Intensification du Traitement du Diabète, Kreaxi, Supernova Invest, Agir A Dom. Holding, Credit Agricole S.A., Investment Arm, Odyssée Venture, SAS, Sofimac Régions SAS, Promontoires, Cemag Invest.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,576 JPY | -0.83% | +1.48% | +11.47% |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare | |
Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.47% | 25.66B | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.24% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
-1.60% | 24.9B |
- Stock Market
- Equities
- 4543 Stock
- News Terumo Corporation
- Diabeloop SAS announced that it has received €70 million in funding from a group of investors